ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC.
- Active Clients
- 1
- TTM Spend
- $700,000
- Total Filings
- 15
- Active Since
- 2023
trailing 4 reported quarters
income + expenses, last 12mo
3 in the last 12 months
4 years with filings
Income & Lobbyist Activity Last 10 years, by quarter
Clients from the last four reported quarters (1) · ranked by reported income and expenses
| Client | Reported $ | Filings | Share |
|---|---|---|---|
| ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC. | $700.0K | 3 | 100.0% |
Issues lobbied last four reported quarters
| Issue | Activities | Share |
|---|---|---|
DEF
Defense
|
3 | 50.0% |
HCR
Health Issues
|
3 | 50.0% |
Government entities contacted last four reported quarters
| Entity | Contacts | Share | Type |
|---|---|---|---|
| Defense, Dept of (DOD) | 6 | 12.8% | Agency |
| HOUSE OF REPRESENTATIVES | 6 | 12.8% | Congress |
| Health & Human Services, Dept of (HHS) | 6 | 12.8% | Agency |
| Natl Security Council (NSC) | 6 | 12.8% | Agency |
| Office of Science & Technology Policy (OSTP) | 6 | 12.8% | Agency |
| SENATE | 6 | 12.8% | Congress |
| Office of the Vice President of the United States | 4 | 8.5% | Agency |
| State, Dept of (DOS) | 4 | 8.5% | Agency |
| Homeland Security, Dept of (DHS) | 3 | 6.4% | Agency |
Revolving door lobbyists active in the last 12 months
0 of 2 lobbyists (0%) listed a prior covered government position on a lobbying filing.
Political contributions semiannual LD-203 reports by the firm and its lobbyists
2 reports on file for 2025 (latest version of each); 0 reported no contributions.
Itemized by year
| Year | Items | Total |
|---|---|---|
| 2025 | 6 | $2,500 |
Largest recipients, 2025
| Recipient | Items | Total |
|---|---|---|
| FRIENDS TO ELECT DR. GREG MURPHY TO CONGRESS honoring Rep. Greg Murphy | 2 | $1,000 |
| STAR PAC honoring Rep. Jack Bergman | 2 | $1,000 |
| MCGUIRE FOR VIRGINIA honoring Rep. John McGuire | 2 | $500 |
Filings 15 total
| Posted | Period | Client | Type | Income | Expenses | Activities | Lobbyists |
|---|---|---|---|---|---|---|---|
| 2026-07-18 | 2026 Q2 | ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC. | 2nd Quarter - Report |
— | $280.0K | 2 | 2 |
| 2026-04-20 | 2026 Q1 | ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC. | 1st Quarter - Report |
— | $220.0K | 2 | 1 |
| 2026-01-21 | 2025 Q4 | ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC. | 4th Quarter - Report |
— | $200.0K | 2 | 1 |
| 2025-10-21 | 2025 Q3 | ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC. | 3rd Quarter - Report |
— | $150.0K | 2 | 1 |
| 2025-07-21 | 2025 Q2 | ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC. | 2nd Quarter - Report |
— | $220.0K | 2 | 1 |
| 2025-04-21 | 2025 Q1 | ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC. | 1st Quarter - Report |
— | $200.0K | 2 | 1 |
| 2025-01-20 | 2024 Q4 | ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC. | 4th Quarter - Report |
— | $170.0K | 2 | 1 |
| 2024-10-21 | 2024 Q3 | ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC. | 3rd Quarter - Report |
— | $130.0K | 2 | 1 |
| 2024-07-19 | 2024 Q2 | ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC. | 2nd Quarter - Report |
— | $110.0K | 2 | 1 |
| 2024-04-22 | 2024 Q1 | ELUSYS THERAPEUTICS INC FKA NIGHTHAWK BIOSCIENCES, INC. | 1st Quarter - Report |
— | $130.0K | 2 | 1 |
Lobbyists active in the last 12 months (2)
- ANNE CHESTER
- RYAN KANE